Qiagen N.V. (QGEN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Core Insights - The company has demonstrated strong performance with a growth rate of approximately 7% in Q1 compared to the previous quarters, resulting in an overall growth rate of 6%, outperforming the industry and market [1] - The company's consumable business, which constitutes 85% of its operations, has shown resilience in a volatile environment, contributing to its strategic advancement [1] - A recent bolt-on acquisition of Parse has been announced, which is seen as a valuable addition to the existing portfolio, highlighting the company's ongoing focus on capital allocation and regular share buybacks since 2012 [2]